Our life sciences & healthcare real estate team works at the forefront of this innovative and rapidly evolving sector, advising global clients and investors on complex real estate developments and opportunities. We devise transformative commercial solutions across the entire life cycle from acquisition and investment to construction, re-purposing, and divestment of real estate assets.
With over 20 years’ experience and in-depth sector knowledge, we have delivered solutions for a broad range of clients from global investors and international corporate organisations to early-stage and innovative start-ups. Our team also works with venture capital and private equity-backed tenants, providing flexible leasing arrangements that present a different risk profile to traditional real estate investments. The complexities in this sector require a creative approach to developing operational infrastructure and agreements that will allow them to adapt, grow, and thrive.
With global operations in pharmaceuticals, biotech, biopharma services, med-tech, and digital health, the life sciences sector supports a pipeline of cutting-edge innovation and high growth potential, offering significant opportunities for all of our real estate clients.
We support clients in building flexible and agile real estate assets that are sustainable, fully responding to continual changes and advances within the life sciences sector & healthcare, and delivering real estate solutions to attract and retain tenants.
As the demand for life science real estate increases, we are uniquely placed to deliver innovative legal and commercial solutions in this sector. Combined with our broader life science & healthcare expertise and established industry networks, our approach is unique and has been pivotal in seeing our clients achieve exponential growth in this sector.
Synapse est notre microsite sur le leadership éclairé, vous connectant avec des nouvelles et des analyses sur les questions juridiques et commerciales dans les sciences de la vie.
From business plan to liquidity - legal guidance for tech companies